Report on Cardiovascular Health and Diseases in China 2023: An Updated Summary

• Published in: Biomedical and environmental sciences Vol. 37; no. 9; pp. 949 - 992
• Main Author: Center For Cardiovascular Diseases The Writing Committee Of The Report On Cardiovascular Health And Diseases In China, National
• Format: Journal Article
• Language: English
• Published: China Elsevier B.V 01.09.2024
• Subjects: Adult; Aged; Basic research; Cardiovascular disease; Cardiovascular Diseases - epidemiology; Cardiovascular Diseases - prevention & control; China - epidemiology; Female; Health economics; Humans; Male; Medical device development; Middle Aged; Mortality; Prevalence; Rehabilitation; Risk factor; Risk Factors; China; Prevalence; Health economics; Basic research; Mortality; Risk factor; Cardiovascular disease; Rehabilitation; Medical device development
• ISSN: 0895-3988; 2214-0190; 2214-0190
• DOI: 10.3967/bes2024.162

Since 1990, China has made considerable progress in resolving the problem of “treatment difficulty” of cardiovascular diseases (CVD). The prevalent unhealthy lifestyle among Chinese residents has exposed a massive proportion of the population to CVD risk factors, and this situation is further worsened due to the accelerated aging population in China. CVD remains one of the greatest threats to the health of Chinese residents. In terms of the proportions of disease mortality among urban and rural residents in China, CVD has persistently ranked first. In 2021, CVD accounted for 48.98% and 47.35% of deaths in rural and urban areas, respectively. Two out of every five deaths can be attributed to CVD. To implement a national policy “focusing on the primary health institute and emphasizing prevention” and truly achieve a shift of CVD prevention and treatment from hospitals to communities, the National Center for Cardiovascular Diseases has organized experts from relevant fields across China to compile the “Report on Cardiovascular Health and Diseases in China” annually since 2005. The 2024 report is established based on representative, published, and high-quality big-data research results from cross-sectional and cohort population epidemiological surveys, randomized controlled clinical trials, large sample registry studies, and typical community prevention and treatment cases, along with data from some projects undertaken by the National Center for Cardiovascular Diseases. These firsthand data not only enrich the content of the current report but also provide a more timely and comprehensive reflection of the status of CVD prevention and treatment in China.